Verition Fund Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,013
| Closed | -$85K | – | 2877 |
|
|
2025
Q1 | $85K | Buy |
+24,013
| New | +$85K | ﹤0.01% | 2499 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2309 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2139 |
|
|
2023
Q4 | – | Sell |
-267,694
| Closed | -$4.9M | – | 1861 |
|
|
2023
Q3 | $4.9M | Buy |
267,694
+46,561
| +21% | +$853K | 0.06% | 394 |
|
|
2023
Q2 | $4.77M | Sell |
221,133
-465
| -0.2% | -$10K | 0.06% | 338 |
|
|
2023
Q1 | $6.5M | Sell |
221,598
-38,953
| -15% | -$1.14M | 0.09% | 261 |
|
|
2022
Q4 | $9.63M | Sell |
260,551
-51,865
| -17% | -$1.92M | 0.15% | 139 |
|
|
2022
Q3 | $8.8M | Sell |
312,416
-637,713
| -67% | -$18M | 0.1% | 213 |
|
|
2022
Q2 | $18.3M | Buy |
950,129
+24,776
| +3% | +$477K | 0.36% | 25 |
|
|
2022
Q1 | $11.9M | Buy |
+925,353
| New | +$11.9M | 0.14% | 80 |
|